GlassScriptPhysician profile
Susan Weitz Jaffe
NPI 1851359632
$478.36
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.00 · 2020: $53.81 · 2023: $168 · 2024: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $346.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $81.89 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $53.23 | 2019-2023 | Vaxneuvance, Gardasil 9, Pneumovax 23 |
| Genzyme Corporation | $47.10 | 2023-2024 | |
| Abbvie INC. | $45.72 | 2023-2024 | |
| Shield Therapeutics INC | $32.16 | 2024 | |
| Allergan, INC. | $29.66 | 2019-2020 | |
| Janssen Biotech, INC. | $25.18 | 2024 | Stelara |
| Xeris Pharmaceuticals, INC. | $24.64 | 2024 | Keveyis |
| Akebia Therapeutics INC | $23.72 | 2024 | Auryxia |
| Amarin Pharma, INC. | $21.16 | 2020 | |
| Lilly USA, LLC | $18.27 | 2023 | Mounjaro |
| Mayne Pharma Commercial LLC | $18.05 | 2023 | |
| Boston Scientific Corporation | $15.97 | 2023 | Wavewriter Alpha Prime 16 |
| Corcept Therapeutics | $15.70 | 2019 | |
| Tactile Systems Technology INC | $14.24 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Jaffe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.